|
Ameloblastoma |
Ameloblastic Carcinoma |
Age |
Wide age range, peak in fourth to fifth decades |
Most cases arise in adults, with peak in fifth to sixth decades |
Location |
Gnathic bones, most often posterior mandible |
Gnathic bones, most often posterior mandible. Cases may arise de novo or in association with preexisting ameloblastoma |
Symptoms |
Slowly growing painless mass, eventually causing facial deformity, loose teeth, or even airway obstruction |
Facial swelling, pain, trismus |
Signs |
Classic radiologic appearance is a multilocular (“soap bubble” or “honeycomb”) radiolucency |
Aggressive radiographic appearance with cortical plate expansion and invasion of nearby tissues |
Etiology |
Unknown |
Unknown |
Histology |
Islands, and/or anastomosing cords of cells
Peripheral layer of palisading columnar cells. The nuclei are hyperchromatic and polarized away from the basement membrane (reverse polarity). Subnuclear cytoplasmic vacuoles are common (Figs. 2.1.1 and 2.1.2)
Central stellate cells are loosely arranged and resemble the stellate reticulum of the developing tooth (Fig. 2.1.2). The stellate cells may show varying degrees of squamous (acanthomatous) or granular change
Tumor nests may become cystic
Mitotic figures are absent or only rarely encountered. No atypical mitotic figures. No necrosis
|
Can exhibit any of the growth patterns seen in benign ameloblastoma including solid islands and anastomosing cords
At least focally exhibit some ameloblastic features including peripheral palisading of columnar cells (Fig. 2.1.3)
Malignant cytologic features that include one or more of the following (Fig. 2.1.4):
|
Special studies |
Immunohistochemistry is not helpful in this differential diagnosis. Most harbor mutations in genes of the MAPK pathway, most frequently BRAF V600E |
Immunohistochemistry is not helpful in this differential diagnosis. Some cases harbor p53 mutations |
Treatment |
Complete resection with a margin of normal bone |
Wide resection with a margin of normal bone. Adjuvant radiation therapy is sometimes employed |
Prognosis |
Benign neoplasm, but with high rate of recurrence, especially after conservative therapy. Rare cases transform into ameloblastic carcinomas, or metastasize without malignant histologic features (“malignant ameloblastoma”) |
Five-year survival is approximately 70%. Recurrences in approximately 30%, metastases (usually lung) in approximately 20%-30% |